International Business News - RDEA http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif A buyout bull's-eye will likely remain on biotechnology companies over the next few years as major pharmaceutical companies continue taking advantage of a weak dollar and a surplus of cash to buy pipeline additions. http://www.ibtimes.com/articles/20080820/biotech-buyout-action-likely-to-continue.htm Wed, 20 Aug 2008 11:41:33 EDT Among the earnings stories for Friday, Aug. 15, from AP Financial News: NEW YORK (AP)--Tongjitang Chinese Medicines Co., a Chinese drug developer, said Friday its second-quarter profit grew sevenfold despite weaker sales of its osteoporosis treatment. http://www.ibtimes.com/articles/20080815/earnings-roundup-tongjitang-american-apparel.htm Fri, 15 Aug 2008 11:18:13 EDT Biotechnology company Ardea Biosciences Inc. said its second-quarter loss nearly tripled as the company ramped up spending for its HIV, gout, cancer and inflammation drugs, and revenue dwindled to nil. http://www.ibtimes.com/articles/20080815/ardea-2q-loss-grows-on-higher-costs-and-no-revenue.htm Fri, 15 Aug 2008 06:53:38 EDT More than 50 companies in the health care sector were added to the Russell 2000 in this year's reconstitution of the small stock index, while 30 companies in the sector were removed from the index. http://www.ibtimes.com/articles/20080630/russell-2000-adds-53-health-care-companies.htm Mon, 30 Jun 2008 14:16:09 EDT Among the stock activity stories for Wednesday, June 25, from AP Financial News: NEW YORK (AP)--Shares of Williams Cos. touched a seven-year high on Wednesday after the oil and natural gas producer and transporter raised its profit outlook for the next two years, predicting higher natural gas prices. http://www.ibtimes.com/articles/20080625/movers-roundup-williams-monaco-coach.htm Wed, 25 Jun 2008 17:30:41 EDT Shares of Ardea Biosciences Inc. rose Wednesday after the company released additional positive data on its midstage HIV drug candidate. Shares rose 75 cents, or 5.8 percent, to $13.65 in afternoon trading. The stock has traded between $5 and $16.25 over the past 52 weeks. http://www.ibtimes.com/articles/20080625/ardea-biosciences-shares-rise-on-hiv-study-data.htm Wed, 25 Jun 2008 15:01:08 EDT